Hot-selling Imatinib Mesylate - Valsartan CAS 137862-53-4 Purity ≥99.0% (HPLC) API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We believe that long term partnership is a result of high quality, value added service, rich experience and personal contact for ATS-8, 15761-39-4, CAS 134395-00-9, Warmly welcome to cooperate and develop with us! we will continue to provide product with high quality and competitive price.
Hot-selling Imatinib Mesylate - Valsartan CAS 137862-53-4 Purity ≥99.0% (HPLC) API High Purity – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Supply Valsartan and Related Intermediates:
Valsartan CAS: 137862-53-4
L-Valine Methyl Ester Hydrochloride (H-Val-OMe·HCl) CAS: 6306-52-1

Chemical Name Valsartan
Synonyms N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine
CAS Number 137862-53-4
CAT Number RF-API32
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C24H29N5O3
Molecular Weight 435.52
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Powder; Odourless, Hygroscopic
Identification IR, HPLC: Must Conform to The Reference Standard
Solubility Soluble in Methanol and Ethanol, Sparingly Soluble in Ethylacetate, Slightly Soluble in Dichloromethane, Insoluble in Water
Moisture (K.F) ≤1.0%
Absorbance (420mm) ≤0.02%
Sulphated Ash ≤0.10%
Heavy Metals ≤10ppm
Related Substances
D-Valsartan ≤1.0% (HPLC)
Butyryl-Valsartan ≤0.20%
Benzyl-Valsartan ≤0.10%
Single Unknown Inpurity ≤0.10%
Total Impurities ≤0.30% (excluding D-Valsartan)
Residual Solvents
Methanol ≤3000ppm
Ethyl Acetate ≤5000ppm
N,N-Dimethylformamide ≤880ppm
Toluene ≤890ppm
Assay 98.0%~102.0% (HPLC)
Test Standard United States Pharmacopoeia (USP)
Usage Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Valsartan (CAS: 137862-53-4) with high quality. Valsartan is a nonpeptide angiotensin II AT1 receptor antagonist, Antihypertensive, has the potential for high blood pressure and heart failure research.
Valsartan’s antihypertensive effects are stronger than those of enalapril and is suitable for treating hypertension, mild to moderate primary hypertension, and especially secondary hypertension caused by renal damage. It can significantly reduce proteinuria for hypertension patients with diabetes or normal liver functions, and it can promote uric acid and urinary sodium to protect the kidney. Valsartan is also suitable for reducing the cardiovascular mortality for high risk patients (left ventricular failure or dysfunction) after experiencing a heart attack.


Product detail pictures:

Hot-selling Imatinib Mesylate - Valsartan CAS 137862-53-4 Purity ≥99.0% (HPLC) API High Purity – Ruifu detail pictures


Related Product Guide:

We pursue the management tenet of "Quality is superior, Service is supreme, Reputation is first", and will sincerely create and share success with all clients for Hot-selling Imatinib Mesylate - Valsartan CAS 137862-53-4 Purity ≥99.0% (HPLC) API High Purity – Ruifu , The product will supply to all over the world, such as: Yemen, Uruguay, Niger, "Create Values,Serving Customer!" is the aim we pursue. We sincerely hope that all customers will establish long term and mutually beneficial cooperation with us.If you wish to get more details about our company, Please contact with us now!
  • The company has rich resources, advanced machinery, experienced workers and excellent services, hope you keep improving and perfecting your products and service, wish you better!
    5 Stars By Ivy from Serbia - 2017.06.16 18:23
    This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Eunice from Russia - 2017.12.02 14:11
    Write your message here and send it to us